What We're Reading: Page 210
Industry reads hand-picked by our editors
Apr 16, 2020
-
The Washington Post
Chaotic search for coronavirus treatments undermines efforts, experts say
-
Bloomberg
Gilead Is Said to Hold Arcus Stake Talks, Spurring 54% Rally
-
In the Pipeline
Coronavirus Vaccine Prospects
-
STAT
Scientists tap CRISPR to create a rapid Covid-19 test
Apr 15, 2020
-
The Atlantic
Our Pandemic Summer
-
The Wall Street Journal
U.S. to Cut Funding to World Health Organization Over Coronavirus Response
-
OneZero
New Testing Tech Could Stop the Next Pandemic
-
POLITICO
FEMA ships out nearly 20 million hydroxychloroquine tablets
Apr 14, 2020
-
The Wall Street Journal
The 49ers Lost the Super Bowl and May Have Saved Lives
-
STAT
Who gets the last ventilator? Pondering the unthinkable amid Covid-19
-
Bloomberg
Stay Home During Outbreak: Americans Stick to Social Distancing
-
The New York TImes
Who Is Immune to the Coronavirus?
Apr 13, 2020
-
The New York Times
How Biogen Became a Coronavirus 'Superspreader'
-
The Wall Street Journal
Trump Retweets Call for Dr. Fauci to Be Fired Over Coronavirus Comments
-
Endpoints
Judge slaps enhanced damages on Gilead/Kite for 'willful' patent violation, boosting award to a blockbuster $1.2B
-
Kaiser Health News
A Colorado Ski Community Planned To Test Everyone For COVID-19. Here’s What Happened.
Apr 09, 2020
Apr 08, 2020
-
The Washington Post
European politicians are making big promises about antibody passports. The science is still catching up.
-
Reuters
U.N. agency says coronavirus emergency could trump some patent rights
-
Science
Former FDA leaders decry emergency authorization of malaria drugs for coronavirus
-
BioCentury
Dealmaking in a pandemic: partnerships speeding COVID-19 countermeasures
Apr 07, 2020
-
Endpoints News
The 20 under 40: Inside the next generation of biopharma leaders
-
STAT
Martin Shkreli is trying to use the coronavirus pandemic to get out of prison
-
Bloomberg
Everything Must Go Right to Find a Fast Coronavirus Vaccine
-
Reuters
Eli Lilly lowers insulin costs as coronavirus crisis deepens